000 03630nam a22003855i 4500
001 281364
003 MX-SnUAN
005 20160429154102.0
007 cr nn 008mamaa
008 150903s2005 ne | o |||| 0|eng d
020 _a9781402028045
_99781402028045
024 7 _a10.1007/1402028040
_2doi
035 _avtls000334162
039 9 _a201509030210
_bVLOAD
_c201404120659
_dVLOAD
_c201404090438
_dVLOAD
_y201402041141
_zstaff
040 _aMX-SnUAN
_bspa
_cMX-SnUAN
_erda
050 4 _aRC261-271
100 1 _aBodey, Bela.
_eautor
_9306980
245 1 0 _aMolecular Markers of Brain Tumor Cells :
_bImplications for Diagnosis, Prognosis and Anti-Neoplastic Biological Therapy /
_cby Bela Bodey, Stuart E. Siegel, Hans E. Kaiser.
264 1 _aDordrecht :
_bSpringer Netherlands,
_c2005.
300 _axvii, 362 páginas
_brecurso en línea.
336 _atexto
_btxt
_2rdacontent
337 _acomputadora
_bc
_2rdamedia
338 _arecurso en línea
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
_2rda
500 _aSpringer eBooks
505 0 _aMolecular Biology of Tumors -- Brain Tumors -- Immunophenotypic Characterization of Infiltrating Poly- and Mononuclear Cells in Childhood Brain Tumors -- Anti-Neoplastic Biological Therapies -- Experimental Therapies in Brain Tumors -- Biologic Anti-Neoplastic Therapies -- The Lymphokine Activeted Killer (LAK) Cell Phenomenon -- Angiogenesis Inhibition in Anti-Neoplastic Therapy -- Antigen Presentation by Dendritic Cells and Their Significance in Anti-Neoplastic Immunotherapy -- Genetically Engineered Antibodies for Direct Anti-Neoplastic Treatment and Systematic Delivery of Various Therapeutic Agents to Cancer Cells -- Cancer-Testis Antigens: Promising Targets for Antigen Directed Anti-Neoplastic Immunotherapy -- Prologue -- Materials and Methods.
520 _aChildhood brain tumors are a diverse group of diseases characterized by the abnormal growth of tissue contained within the skull. Other than leukemia and lymphoma, brain tumors are the most common type of neoplasms that occur in children. The leading cause of death from childhood neoplasms among persons up to 19 years is brain tumors. As such, this book is a review of the most recent molecular biological research concerning brain tumors with references and comparisons to a variety of neoplastic disorders. The book then uses this information to foreshadow the direction that future anti-neoplastic therapies will take. Because of the wide spectrum of the objectives of the book, any individual involved in cancer research will greatly benefit from the work. Histopathologists, neuropathologists, clinical and research oncologists, and medical students will find this book to be an invaluable resource as a reference guide. Patients and their families will also find the book useful as it offers a comprehensive update on new, non-classical therapeutic modality options and contains a detailed description and analysis of brain tumors. Such an endeavor has yet to be undertaken by any other book and may prove to be the most comprehensive book on brain tumors thus far.
590 _aPara consulta fuera de la UANL se requiere clave de acceso remoto.
700 1 _aSiegel, Stuart E.
_eautor
_9306981
700 1 _aKaiser, Hans E.
_eautor
_9306982
710 2 _aSpringerLink (Servicio en línea)
_9299170
776 0 8 _iEdición impresa:
_z9781402027819
856 4 0 _uhttp://remoto.dgb.uanl.mx/login?url=http://dx.doi.org/10.1007/1-4020-2804-0
_zConectar a Springer E-Books (Para consulta externa se requiere previa autentificación en Biblioteca Digital UANL)
942 _c14
999 _c281364
_d281364